Science Explorer Back to mapMap
Discussion
Researcher · BC Cancer Agency · Canada

Christian Steidl

Christian Steidl publishes mostly in Pathology and Forensic Medicine, Molecular Biology and Oncology, on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and CAR-T cell therapy research.

ORCID 0000-0001-9842-9750 OpenAlex
World rank
#58,856
of 7,710,434 ranked researchers
Rank in Canada
#1,680
of 183,316
Works
650
Citations
24k
Citations per work
36.5
h-index
80
i10-index 199Top 1% in Pathology and Forensic Medicine
Christian Steidl

What does Christian Steidl research?

Christian Steidl's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (9%).

Health Sciences: 322 works · 49.5% of their workMedicine: 322 works · 49.5% of their workPathology and Forensic Medicine: 185 works · 28.5% of their workOncology: 86 works · 13.3% of their workGenetics: 50 works · 7.7% of their workLife Sciences: 196 works · 30.2% of their workBiochemistry, Genetics and Molecular Biology: 140 works · 21.5% of their workMolecular Biology: 103 works · 15.8% of their workCancer Research: 37 works · 5.7% of their workImmunology and Microbiology: 57 works · 8.7% of their workImmunology: 57 works · 8.7% of their workEverything else: 132 works · 20.3% of their workTHEIR WORKChristian Steidl650works
Life Sciences30%Health Sciences50%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine32249.5%
    1. Biochemistry, Genetics and Molecular Biology14021.5%
    2. Immunology and Microbiology578.7%
  3. Everything else13220.3%
  1. 1Pathology and Forensic Medicine28% of their works
  2. 2Molecular Biology16% of their works
  3. 3Oncology13% of their works
  4. 4Immunology9% of their works
  5. 5Genetics8% of their works
  6. 6Cancer Research6% of their works

Research topics

Which keywords describe Christian Steidl's research?

The keywords of their largest research topics: Rituximab, Lymphoma, Classification, Molecular Profiling, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations and CAR T Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Rituximab4222 topics
  2. Lymphoma4192 topics
  3. Classification3361 topic
  4. Molecular Profiling3361 topic
  5. Prognostic Factors1282 topics
  6. Chronic Lymphocytic Leukemia861 topic
  7. Genomic Aberrations861 topic
  8. CAR T Cells831 topic
  9. Chimeric Antigen Receptor831 topic
  10. Cancer Genomics571 topic
  11. Mutational Signatures571 topic
  12. NK Cell Recognition531 topic
  13. Natural Killer Cells531 topic
  14. AML421 topic
  15. Acute Myeloid Leukemia421 topic
  16. Primary CNS Lymphoma411 topic
  17. Prognostic Scoring System411 topic
  18. Single-Cell371 topic
  19. Transcriptomics371 topic

Where does Christian Steidl work?

Christian Steidl's main affiliation in the publication record is BC Cancer Agency, Canada.

How many publications and citations does Christian Steidl have?

OpenAlex counts 650 works and 23,699 citations for Christian Steidl, an h-index of 80, ranking #58,856 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Christian Steidl. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.